Patents by Inventor Gary Conard Visor

Gary Conard Visor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140039002
    Abstract: The present invention provides solid forms of the compound of formula 1 and pharmaceutical uses thereof.
    Type: Application
    Filed: February 21, 2012
    Publication date: February 6, 2014
    Applicants: F. Hoffmann-La Roche AG, Plexxikon Inc.
    Inventors: Ralph Diodone, Karsten Fähnrich, Urs Schwitter, Shan-Ming Kuang, Baoshu Zhao, Prabha N. Ibrahim, Gary Conard Visor
  • Publication number: 20120122860
    Abstract: Solid forms of phenyl sulfonamide compounds of formula (I) active on protein kinases, including Raf protein kinases, are described, as well as methods of using such solid forms to treat diseases and conditions associated with activity of protein kinases, e.g. Raf protein kinases, including pain, polycystic kidney disease, melanoma and colorectal cancer.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 17, 2012
    Inventors: Gary Conard Visor, Prabha N. Ibrahim, Wayne Spevak, Hanna Cho, Songyuan Shi, Guoxian Wu
  • Publication number: 20040170689
    Abstract: This invention relates to new stable oral pharmaceutical formulations prepared by covering an nucleus formed by a core with a first hydrophobic polymer layer, a second layer coating the first layer, wherein said second layer comprises one or more labile pharmaceutical compounds in one or more acceptable hydrophobic excipients, and an optional third enteric polymer layer.
    Type: Application
    Filed: March 11, 2004
    Publication date: September 2, 2004
    Inventors: Debra Alida Odink, I-Lan Sue, Gary Conard Visor
  • Publication number: 20020086057
    Abstract: This invention relates to new stable oral pharmaceutical formulations prepared by covering an nucleus formed by a core with a first hydrophobic polymer layer, a second layer coating the first layer, wherein said second layer comprises one or more labile pharmaceutical compounds in one or more acceptable hydrophobic excipients, and an optional third enteric polymer layer.
    Type: Application
    Filed: November 9, 2001
    Publication date: July 4, 2002
    Inventors: Debra Alida Odink, I-Lan Sue, Gary Conard Visor